AARD
Income statement / Annual
Last year (2025), Aardvark Therapeutics Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Aardvark Therapeutics Inc.'s net income was -$57.59 M.
See Aardvark Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$36.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$36.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$48.94 M
|
$17.36 M
|
$4.48 M
|
$7.17 M
|
| General & Administrative Expenses |
$13.79 M
|
$5.31 M
|
$2.17 M
|
$2.70 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$13.79 M
|
$5.31 M
|
$2.17 M
|
$2.70 M
|
| Other Expenses |
$0.00
|
$117.00 K
|
$762.00 K
|
$1.49 M
|
| Operating Expenses |
$62.73 M
|
$22.79 M
|
$7.42 M
|
$11.36 M
|
| Cost And Expenses |
$62.73 M
|
$22.79 M
|
$7.42 M
|
$11.36 M
|
| Interest Income |
$5.14 M
|
$2.41 M
|
$1.42 M
|
$120.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$16.00 K
|
$0.00
|
$110.00 K
|
| EBITDA |
-$62.73 M |
-$22.65 M |
-$6.65 M |
-$9.76 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$5.13 M
|
$2.20 M
|
$207.00 K
|
-$2.20 M
|
| Income Before Tax |
-$57.59 M
|
-$20.59 M
|
-$7.21 M
|
-$13.56 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$57.59 M
|
-$20.59 M
|
-$7.21 M
|
-$13.56 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
| EPS |
-2.64 |
-0.95 |
-0.34 |
-0.63 |
| EPS Diluted |
-2.64 |
-0.95 |
-0.34 |
-0.63 |
| Weighted Average Shares Out |
$21.82 M
|
$21.70 M
|
$21.38 M
|
$21.38 M
|
| Weighted Average Shares Out Diluted |
$21.82 M
|
$21.70 M
|
$21.38 M
|
$21.38 M
|
| Link |
|
|
|
|
